Approval · Notice of Compliance 3753 · 1997
PENTA-DOXYCYCLINE: Notice of Compliance 3753
Issued July 29, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3753
- Date
- July 29, 1997
- Company
- Pentapharm Ltd.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Broad spectrum antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTA-DOXYCYCLINE | 02231771 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- DOXYCYCLINE 100 MG per TAB